Reduced bone mineral density and altered bone turnover markers in patients with non-cirrhotic chronic hepatitis B or C infection

World Journal of Gastroenterology

Volumn 11, Issue 12, 2005, Pages 1843-1847

  Schiefke, Ingolf ^a   Fach, Andreas ^a   Wiedmann, Marcus ^a   Aretin, Andreas V ^a   Schenker, Eva ^a   Borte, Gudrun ^a   Wiese, Manfred ^b   Moessne, Joachim ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b Klinikum St Georg   (Germany)

Author keywords

Bone density; Chronic viral hepatitis; Non cirrhotic patients

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ALKALINE PHOSPHATASE BONE ISOENZYME; CALCIFEDIOL; CALCITRIOL; CALCIUM; CALCIUM ION; CREATININE; DEOXYPYRIDINOLINE; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; PARATHYROID HORMONE; PHOSPHATE; PYRIDINOLINE; VIRUS DNA; VIRUS RNA;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BONE DENSITOMETRY; BONE DENSITY; BONE METABOLISM; BONE TURNOVER; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR NECK; HEPATITIS B; HEPATITIS C; HUMAN; LIVER FIBROSIS; LUMBAR SPINE; MALE; OSTEOPOROSIS; POLYMERASE CHAIN REACTION; QUANTITATIVE ANALYSIS; STATISTICAL SIGNIFICANCE;

EID: 17144399925     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i12.1843     Document Type: Article

References (32)

1. Iber F. Bone disease in chronic liver disease. Am J Gastroenterol 1989; 84: 1229-1230
2. Rouillard S, Lane NE. Hepatic osteodystrophy. Hepatology 2001; 33: 301-307
3. Stellon AJ, Webb A, Compston JE. Bone histomorphometry and structure in corticosteroid treated chronic active hepatitis. Gut 1988; 29: 378-384
4. Hodgson SF, Dickson ER, Wahner HW, Johnson KA, Mann KG, Riggs BL. Bone loss and reduced osteoblast function in primary biliary cirrhosis. Ann Intern Med 1985; 103: 855-860
5. Guanabens N, Pares A, Marinoso L, Brancos MA, Piera C, Serrano S, Rivera F, Rodes J. Factors influencing the development of metabolic bone disease in primary biliary cirrhosis. Am J Gastroenterol 1990; 85: 1356-1362
6. Bonkovsky HL, Hawkins M, Steinberg K, Hersh T, Galambos JT, Henderson JM, Millikan WJ, Galloway JR. Prevalence and prediction of osteopenia in chronic liver disease. Hepatology 1990; 12: 273-280
7. Gonzalez-Calvin JL, Garcia-Sanchez A, Bellot V, Munoz-Torres M, Raya-Alvarez E, Salvatierra-Rios D. Mineral metabolism, osteoblastic function and bone mass in chronic alcoholism. Alcohol Alcohol 1993; 28: 571-579
8. Gallego-Rojo FJ, Gonzalez-Calvin JL, Munoz-Torres M, Mundi JL, Fernandez-Perez R, Rodrigo-Moreno D. Bone mineral density, serum insulin-like growth factor I, and bone turnover markers in viral cirrhosis. Hepatology 1998; 28: 695-699
9. Ross PD, Davis JW, Epstein RS, Wasnich RD. Pre-existing fractures and bone mass predict vertebral fracture incidence in women. Ann Intern Med 1991; 114: 919-923
10. Cummings SR, Black DM, Nevitt MC, Browner W, Cauley J, Ensrud K, Genant HK, Palermo L, Scott J, Vogt TM. Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group. Lancet 1993; 341: 72-75
11. Cuthbert JA, Pak CY, Zerwekh JE, Glass KD, Combes B. Bone disease in primary biliary cirrhosis: Increased bone resorption and turnover in the absence of osteoporosis or osteomalacia. Hepatology 1984; 4: 1-8
12. Hay JE, Lindor KD, Wiesner RH, Dickson ER, Krom RA, LaRusso NF. The metabolic bone disease of primary sclerosing cholangitis. Hepatology 1991; 14: 257-261
13. Trautwein C, Possienke M, Schlitt HJ, Boker KH, Horn R, Raab R, Manns MP, Brabant G. Bone density and metabolism in patients with viral hepatitis and cholestatic liver diseases before and after liver transplantation. Am J Gastroenterol 2000; 95: 2343-2351
14. Silvennoinen JA, Lehtola JK, Niemela SE. Smoking is a risk factor for osteoporosis in women with inflammatory bowel disease. Scand J Gastroenterol 1996; 31: 367-371
15. Hay JE. Bone disease in cholestatic liver disease. Gastroenterology 1995; 108: 276-283
16. Diamond T, Stiel D, Lunzer M, Wilkinson M, Posen S. Ethanol reduces bone formation and may cause osteoporosis. Am J Med 1989; 86: 282-288
17. Compston JE. Hepatic osteodystrophy: Vitamin D metabolism in patients with liver disease. Gut 1986; 27: 1073-1090
18. Duarte MP, Farias ML, Coelho HS, Mendonca LM, Stabnov LM, Oliveira MD, Lamy RA, Oliveira DS. Calcium-parathyroid hormone-vitamin D axis and metabolic bone disease in chronic viral liver disease. J Gastroenterol Hepatol 2001; 16: 1022-1027
19. Olsson R, Johansson C, Lindstedt G, Mellstrom D. Risk factors for bone loss in chronic active hepatitis and primary biliary cirrhosis. Scand J Gastroenterol 1994; 29: 753-756
20. Solis-Herruzo JA, Castellano G, Fernandez I, Munoz R, Hawkins F. Decreased bone mineral density after therapy with alpha interferon in combination with ribavirin for chronic hepatitis C. J Hepatol 2000; 33: 812-817
21. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, Wollman J. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1: 431-435
22. Lehmann R, Wapniarz M, Randerath O, Kvasnicka HM, John W, Reincke M, Kutnar S, Klein K, Allolio B. Dual-energy X-ray absorptiometry at the lumbar spine in German men and women: A cross-sectional study. Calcif Tissue Int 1995; 56: 350-354
23. Kanis JA, An update on the diagnosis of osteoporosis. Curr Rheumatol Rep 2000; 2: 62-66
24. Diamond T, Stiel D, Mason R, Lissner D, Bikle D, Wilson S, Posen S. Serum vitamin D metabolites are not responsible for low turnover osteoporosis in chronic liver disease. J Clin Endocrinol Metab 1989; 69: 1234-1239
25. Diamond TH, Stiel D, Lunzer M, McDowall D, Eckstein RP, Posen S. Hepatic osteodystrophy. Static and dynamic bone histomorphometry and serum bone Gla-protein in 80 patients with chronic liver disease. Gastroenterology 1989; 96: 213-221
26. Monegal A, Navasa M, Guanabens N, Peris P, Pons F, Martinez de Osaba MJ, Rimola A, Rodes J, Munoz-Gomez J. Osteoporosis and bone mineral metabolism disorders in cirrhotic patients referred for orthotopic liver transplantation. Calcif Tissue Int 1997; 60: 148-154
27. Hay JE. Osteoporosis in liver diseases and after liver transplantation. J Hepatol 2003; 38: 856-865
28. Conte D, Caraceni NW, Duriez J, Mandelli C, Corghi E, Cesana M, Ortolani S, Bianchi PA. Bone involvement in primary hemochromatosis and alcoholic cirrhosis. Am J Gastroenterol 1989; 84: 1231-1234
29. Seibel MJ, Cosman F, Shen V, Gordon S, Dempster DW, Ratcliffe A, Lindsay R. Urinary hydroxypyridinium crosslinks of collagen as markers of bone resorption and estrogen efficacy in post-menopausal osteoporosis. J Bone Miner Res 1993; 8: 881-889
30. Eriksen EF, Brixen K, Charles P. New markers of bone metabolism: Clinical use in metabolic bone disease. Eur J Endocrinol 1995; 132: 251-263
31. Tsuneoka K, Tameda Y, Takase K, Nakano T. Osteodystrophy in patients with chronic hepatitis and liver cirrhosis. J Gastroenterol 1996; 31: 669-678
32. Harris WH, Heaney RP. Skeletal renewal and metabolic bone disease. N Engl J Med 1969; 280: 303-311